Insulet has signed a five-year agreement that will see Swiss firm Ypsomed Distribution exclusively market its OmniPod Insulin Management System in 11 countries. The deal could be worth more than $100 million. Ypsomed will start distributing the product in Western Europe and Australia during the next six months and introduce it in China by early next year.

Related Summaries